Concepedia

Kang He

KH

Statistics

Publications

8

Citations

340

H-Index

8

Active since

2015

Affiliations

Nanjing Medical University(Current)

Jiangsu Cancer Hospital

Xi'an Jiaotong University

Kang He is an author at Nanjing Medical University specializing in oncology, medicine, and molecular oncology.

Publications per year

2015–2022

8

Publications

8

Preoperative Systemic Immune–Inflammation Index (SII) as a Superior Predictor of Long-Term Survival Outcome in Patients With Stage I–II Gastric Cancer After Radical Surgery

Kang He, Lixiang Si, Xiaohua Pan et al. · Frontiers in Oncology · 2022 · 98 citations · Full text

Medicine, Oncology, Surgery +17

MicroRNA-101 suppresses progression of lung cancer through the PTEN/AKT signaling pathway by targeting DNA methyltransferase 3A

Lumin Wang, Jiayi Yao, Hongfei Sun et al. · Oncology Letters · 2016 · 62 citations · Full text

Life Sciences, Genetics, Oncology +17

<p>Plasma cfDNA as a Potential Biomarker to Evaluate the Efficacy of Chemotherapy in Gastric Cancer</p>

Yuejiao Zhong, Qingyu Fan, Zhaofei Zhou et al. · Cancer Management and Research · 2020 · 55 citations · Full text

Medicine, Molecular Biology, Oncology +14

<p>KRAS Codon 12 Mutation is Associated with More Aggressive Invasiveness in Synchronous Metastatic Colorectal Cancer (mCRC): Retrospective Research</p>

Kang He, Yajing Wang, Yuejiao Zhong et al. · OncoTargets and Therapy · 2020 · 35 citations · Full text

Medicine, Oncology, Pathology +17

A cohort study of the efficacy and safety of immune checkpoint inhibitors plus anlotinib versus immune checkpoint inhibitors alone as the treatment of advanced non-small cell lung cancer in the real world

Yue Shi, Min Ji, Yingying Jiang et al. · Translational Lung Cancer Research · 2022 · 28 citations · Full text

Medicine, Oncology, Pharmacology +16

1–5 of 8